UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CAG repeat size in Huntingtin alleles is associated with cancer prognosis

European journal of human genetics : EJHG, 2016-08, Vol.24 (9), p.1310-1315

2016

Volltextzugriff (PDF)

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Human mutation, 2018-05, Vol.39 (5), p.593-620

2018

Volltextzugriff (PDF)

BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry

Human mutation, 2019-10, Vol.40 (10), p.1781-1796

2019

Volltextzugriff (PDF)

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Nature genetics, 2020-06, Vol.52 (6), p.572-581

2020

Volltextzugriff (PDF)

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

Journal of clinical oncology, 2017-07, Vol.35 (20), p.2240-2250

2017

Volltextzugriff (PDF)

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

Nature genetics, 2016-04, Vol.48 (4), p.374-386

2016

Volltextzugriff (PDF)

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

JNCI : Journal of the National Cancer Institute, 2019-04, Vol.111 (4), p.350-364

2019

Volltextzugriff (PDF)

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Nature genetics, 2017-12, Vol.49 (12), p.1767-1778

2017

Volltextzugriff (PDF)

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Nature genetics, 2020-01, Vol.52 (1), p.56-73

2020

Volltextzugriff (PDF)

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers

Frontiers in oncology, 2018-10, Vol.8, p.490-490

2018

Volltextzugriff (PDF)

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (3), p.624-638

2020

Volltextzugriff (PDF)

Olfactory Evoked Brainstem Autonomic Responses in Subjects with Normal Sensations of Smell

Autonomic neuroscience, 2015-11, Vol.192, p.83-84

2015

Volltextzugriff (PDF)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Nature communications, 2019-04, Vol.10 (1), p.1741-18, Article 1741

2019

Volltextzugriff (PDF)

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Nature genetics, 2017-05, Vol.49 (5), p.680-691

2017

Volltextzugriff (PDF)

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

BMC medical research methodology, 2021-07, Vol.21 (1), p.1-155, Article 155

2021

Volltextzugriff (PDF)

The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

Human mutation, 2011-09, Vol.32 (9), p.1004-1007

2011

Volltextzugriff (PDF)

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

PloS one, 2015-04, Vol.10 (4), p.e0120020

2015

Volltextzugriff (PDF)

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

Nature genetics, 2010-10, Vol.42 (10), p.885-892

2010

Volltextzugriff (PDF)

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

Breast cancer research and treatment, 2017-01, Vol.161 (1), p.117-134

2017

Volltextzugriff (PDF)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Nature communications, 2021-02, Vol.12 (1), p.1078-22, Article 1078

2021

Volltextzugriff (PDF)

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Genetics in medicine, 2021-09, Vol.23 (9), p.1726-1737

2021

Volltextzugriff (PDF)

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Breast cancer research : BCR, 2012-02, Vol.14 (1), p.R33-R33

2012

Volltextzugriff (PDF)

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Genetics in medicine, 2020-10, Vol.22 (10), p.1653-1666

2020

Volltextzugriff (PDF)

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

PLoS genetics, 2013, Vol.9 (3), p.e1003212-e1003212

2013

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(166)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants

CAG repeat size in Huntingtin alleles is associated with cancer prognosis

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Olfactory Evoked Brainstem Autonomic Responses in Subjects with Normal Sensations of Smell

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Suchergebnisse filtern